United States

InspireMD Inc (NSPR.A)

NSPR.A on American Stock Exchange

25 Apr 2017
Change (% chg)

$0.02 (+2.62%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for NSPR.A


InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard... (more)
No analyst recommendations are available for NSPR.A.


Beta: 2.28
Market Cap(Mil.): $0.95
Shares Outstanding(Mil.): 1.47
Dividend: --
Yield (%): --


  NSPR.A Industry Sector
P/E (TTM): -- 34.82 30.10
EPS (TTM): -14.32 -- --
ROI: -484.67 12.74 13.21
ROE: -1,539.58 14.80 14.37

BRIEF-InspireMD reports Q3 loss per share $0.86

* InspireMD reports financial results for the third quarter ended September 30, 2016

Nov 14 2016

BRIEF-Inspiremd Inc received approval to commercialize CGuard embolic prevention system

* Inspiremd Inc - received regulatory approval to commercialize cguard embolic prevention system for treatment of carotid artery disease in Russia Source text for Eikon: Further company coverage:

Nov 14 2016

BRIEF-InspireMD names Agustin Gago chief commercial officer

* InspireMD announces appointment of medical device industry veteran Agustin Gago as chief commercial officer Source text for Eikon: Further company coverage:

Oct 26 2016

More From Around the Web

Earnings vs. Estimates